Sintx Technologies, Inc. (SINT)
USD 2.5
(-3.47%)
USD 2.5
(-3.47%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.6 Million USD | -17.4% |
| 2022 | -11.05 Million USD | -12.99% |
| 2021 | -8.63 Million USD | -2.09% |
| 2020 | -6.52 Million USD | -53.57% |
| 2019 | -4.32 Million USD | 24.41% |
| 2018 | -8.19 Million USD | 26.09% |
| 2017 | -11.05 Million USD | -4.91% |
| 2016 | -8.31 Million USD | 10.37% |
| 2015 | -17.42 Million USD | 55.67% |
| 2014 | -26.59 Million USD | -197.77% |
| 2013 | -4.22 Million USD | 14.61% |
| 2012 | -9.5 Million USD | 7.26% |
| 2011 | -14.58 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.77 Million USD | 75.23% |
| 2024 Q2 | -2.3 Million USD | -286.42% |
| 2023 Q4 | -2.27 Million USD | 37.05% |
| 2023 FY | - USD | -17.4% |
| 2023 Q1 | -3.17 Million USD | -33.71% |
| 2023 Q2 | -3.01 Million USD | 5.07% |
| 2023 Q3 | -3.61 Million USD | -19.99% |
| 2022 Q1 | -2.67 Million USD | -42.8% |
| 2022 Q2 | -2.41 Million USD | 9.82% |
| 2022 Q3 | -2.5 Million USD | -3.48% |
| 2022 Q4 | -2.37 Million USD | 5.08% |
| 2022 FY | - USD | -12.99% |
| 2021 Q3 | -2.65 Million USD | -30.37% |
| 2021 Q1 | -2.25 Million USD | -14.56% |
| 2021 Q2 | -2.03 Million USD | 9.42% |
| 2021 FY | - USD | -2.09% |
| 2021 Q4 | -1.87 Million USD | 29.39% |
| 2020 FY | - USD | -53.57% |
| 2020 Q1 | -1.62 Million USD | -41.28% |
| 2020 Q2 | -1.77 Million USD | -9.15% |
| 2020 Q3 | -2.02 Million USD | -13.78% |
| 2020 Q4 | -1.96 Million USD | 2.92% |
| 2019 Q2 | -1.33 Million USD | 15.75% |
| 2019 Q4 | -1.15 Million USD | 26.09% |
| 2019 FY | - USD | 24.41% |
| 2019 Q1 | -1.58 Million USD | -5.05% |
| 2019 Q3 | -1.56 Million USD | -17.12% |
| 2018 Q1 | -1.86 Million USD | 61.43% |
| 2018 FY | - USD | 26.09% |
| 2018 Q3 | -1.2 Million USD | 50.64% |
| 2018 Q4 | -1.5 Million USD | -25.21% |
| 2018 Q2 | -2.43 Million USD | -30.91% |
| 2017 Q1 | -1.5 Million USD | 48.16% |
| 2017 FY | - USD | -4.91% |
| 2017 Q4 | -4.82 Million USD | -111.26% |
| 2017 Q3 | -2.28 Million USD | -56.48% |
| 2017 Q2 | -1.45 Million USD | 3.12% |
| 2016 Q1 | -1.97 Million USD | 7.08% |
| 2016 FY | - USD | 10.37% |
| 2016 Q4 | -2.9 Million USD | 9.42% |
| 2016 Q2 | -1.99 Million USD | -1.17% |
| 2016 Q3 | -3.2 Million USD | -60.91% |
| 2015 FY | - USD | 55.67% |
| 2015 Q4 | -2.12 Million USD | 31.12% |
| 2015 Q3 | -3.07 Million USD | -18.57% |
| 2015 Q2 | -2.59 Million USD | 24.82% |
| 2015 Q1 | -3.45 Million USD | -6.31% |
| 2014 Q1 | -3.49 Million USD | -50.35% |
| 2014 FY | - USD | -197.77% |
| 2014 Q4 | -3.24 Million USD | 35.53% |
| 2014 Q3 | -5.03 Million USD | 52.57% |
| 2014 Q2 | -10.62 Million USD | -203.95% |
| 2013 Q1 | -2.13 Million USD | 54.37% |
| 2013 Q3 | -1.48 Million USD | 31.24% |
| 2013 Q4 | -2.32 Million USD | -56.14% |
| 2013 Q2 | -2.16 Million USD | -1.51% |
| 2013 FY | - USD | 14.61% |
| 2012 Q3 | -1.02 Million USD | 0.0% |
| 2012 FY | - USD | 7.26% |
| 2012 Q4 | -4.67 Million USD | -356.2% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 51.064% |
| Cerus Corporation | -26.53 Million USD | 75.128% |
| OrthoPediatrics Corp. | -8.38 Million USD | 21.25% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 37.11% |
| Talis Biomedical Corporation | -66.04 Million USD | 90.007% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 60.42% |
| Inogen, Inc. | -45.67 Million USD | 85.551% |
| Spectral AI, Inc. | -12.26 Million USD | 46.175% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 86.161% |
| CVRx, Inc. | -38.73 Million USD | 82.959% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -87.075% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 45.486% |
| Orthofix Medical Inc. | -86.98 Million USD | 92.412% |
| Venus Concept Inc. | -26.11 Million USD | 74.725% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 86.739% |
| Bioventus Inc. | -23.07 Million USD | 71.391% |
| BrainsWay Ltd. | -2.31 Million USD | -185.591% |
| Envoy Medical, Inc. | -18.23 Million USD | 63.812% |
| electroCore, Inc. | -17.76 Million USD | 62.838% |
| IceCure Medical Ltd | -15.25 Million USD | 56.73% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 86.734% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 60.844% |
| MaxCyte, Inc. | -44.12 Million USD | 85.044% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 43.858% |
| Nexalin Technology, Inc. | -5.69 Million USD | -15.951% |
| PAVmed Inc | -75.74 Million USD | 91.286% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 87.723% |
| RxSight, Inc. | -41.03 Million USD | 83.917% |
| Sight Sciences, Inc. | -49.41 Million USD | 86.644% |
| SI-BONE, Inc. | -34.44 Million USD | 80.84% |
| TELA Bio, Inc. | -40.63 Million USD | 83.757% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 88.679% |
| Treace Medical Concepts, Inc. | -39 Million USD | 83.08% |
| LivaNova PLC | 39.01 Million USD | 116.916% |
| 908 Devices Inc. | -34.02 Million USD | 80.602% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 94.032% |
| Nemaura Medical Inc. | -7.28 Million USD | 9.428% |
| NeuroPace, Inc. | -22.83 Million USD | 71.096% |
| LENSAR, Inc. | -8.71 Million USD | 24.26% |
| Apyx Medical Corporation | -18.11 Million USD | 63.56% |
| Cutera, Inc. | -136.56 Million USD | 95.167% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -95.266% |
| BioSig Technologies, Inc. | -28.15 Million USD | 76.555% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 362.321% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 68.555% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 101.721% |
| Axonics, Inc. | 7.77 Million USD | 184.887% |
| Outset Medical, Inc. | -153.78 Million USD | 95.708% |
| IRIDEX Corporation | -7.44 Million USD | 11.386% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 93.272% |
| IRadimed Corporation | 20.8 Million USD | 131.73% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 18.134% |
| INVO Bioscience, Inc. | -6.88 Million USD | 4.07% |
| Telesis Bio, Inc. | -40.49 Million USD | 83.701% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 117.995% |
| Varex Imaging Corporation | 67.2 Million USD | 109.821% |
| Quipt Home Medical Corp. | 44.07 Million USD | 114.976% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 39.282% |
| Pulmonx Corporation | -55.09 Million USD | 88.02% |
| Dynatronics Corporation | -976 Thousand USD | -576.224% |
| Modular Medical, Inc. | -17.1 Million USD | 61.41% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 54.436% |
| Semler Scientific, Inc. | 23.58 Million USD | 127.979% |
| InMode Ltd. | 196.28 Million USD | 103.362% |
| Bruker Corporation | 599 Million USD | 101.102% |
| Cytosorbents Corporation | -28.81 Million USD | 77.092% |
| DexCom, Inc. | 916.7 Million USD | 100.72% |
| Align Technology, Inc. | 799.03 Million USD | 100.826% |
| Viveve Medical, Inc. | -20.61 Million USD | 67.988% |
| ZimVie Inc. | 91.07 Million USD | 107.247% |
| Movano Inc. | -29.12 Million USD | 77.339% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -49.728% |
| Nexalin Technology, Inc. | -5.69 Million USD | -15.951% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -87.075% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 96.609% |
| Profound Medical Corp. | -27.12 Million USD | 75.667% |
| Insulet Corporation | 323.6 Million USD | 102.04% |
| enVVeno Medical Corporation | -25.01 Million USD | 73.619% |
| Surmodics, Inc. | 1.18 Million USD | 655.556% |
| iCAD, Inc. | -6.56 Million USD | -0.533% |
| Nuwellis, Inc. | -16.35 Million USD | 59.648% |
| Biotricity, Inc. | -8.82 Million USD | 25.24% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 93.186% |
| Aethlon Medical, Inc. | -11.84 Million USD | 44.3% |
| InspireMD, Inc. | -20.91 Million USD | 68.438% |
| PAVmed Inc. | -75.74 Million USD | 91.286% |
| BIOLASE, Inc. | -15.13 Million USD | 56.404% |
| Beyond Air, Inc. | -59.03 Million USD | 88.819% |
| FONAR Corporation | 28.25 Million USD | 123.362% |
| AxoGen, Inc. | -13.32 Million USD | 50.48% |
| Vivani Medical, Inc. | -26.6 Million USD | 75.195% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 126.894% |
| Inari Medical, Inc. | 7.11 Million USD | 192.788% |
| UFP Technologies, Inc. | 72.74 Million USD | 109.073% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -94.933% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -7.213% |
| Tenon Medical, Inc. | -15.52 Million USD | 57.496% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 56.767% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 84.087% |
| AdaptHealth Corp. | -171.09 Million USD | 96.142% |
| NanoVibronix, Inc. | -3.43 Million USD | -92.14% |
| Quanterix Corporation | -38.08 Million USD | 82.672% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 39.282% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 22100.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 97.62% |
| TransMedics Group, Inc. | -7.6 Million USD | 13.192% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 69.676% |
| NeuroMetrix, Inc. | -7.09 Million USD | 6.987% |
| Hyperfine, Inc. | -47.06 Million USD | 85.976% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 88.681% |
| Biomerica, Inc. | -5.99 Million USD | -10.128% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1476.227% |
| AVITA Medical, Inc. | -39.56 Million USD | 83.32% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 28.049% |
| Silk Road Medical, Inc | -45.08 Million USD | 85.359% |